The MUC1‐related Tn, TF, STn, and STF TACAs, expressed in more than 90% of primary adenocarcinomas, are considered pancarcinoma antigens and have been widely used to design cancer vaccines. The gene discussed is EEF1A2; the disease is adenocarcinoma.